Next-Generation Sequencing May Discriminate Extreme Long-term versus Short-term Survival in Patients with Metastatic Small Cell Lung Cancer (SCLC)
BACKGROUND: Molecular underpinnings that may prognosticate survival could increase understanding of small cell lung cancer (SCLC) tumor behavior. Here, we report the clinicopathological characteristics and biomarker profiles of short-term (ST) versus long-term (LT) survival in patients with metastat...
Main Authors: | Zoltan Lohinai, Zsolt Megyesfalvi, Balazs Dome, Glen J. Weiss |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2019-12-01
|
Series: | Translational Oncology |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1936523319302451 |
Similar Items
-
From Bench to Bedside: Attempt to Evaluate Repositioning of Drugs in the Treatment of Metastatic Small Cell Lung Cancer (SCLC).
by: Zoltan Lohinai, et al.
Published: (2016-01-01) -
Characterization of a new small cell lung cancer (SCLC) cell line STP54 derived from a metastatic bioptate of a combined type of SCLC with Non-SCLC component.
by: Joanna Domagała-Kulawik, et al.
Published: (2009-05-01) -
Neuroendocrine subtypes of small cell lung cancer differ in terms of immune microenvironment and checkpoint molecule distribution
by: David Dora, et al.
Published: (2020-09-01) -
Pathology and Classification of SCLC
by: Maria Gabriela Raso, et al.
Published: (2021-02-01) -
AN UNORTHODOX PRESENTATION OF SCLC
by: Ruchee Khanna
Published: (2018-10-01)